Combined Intravenous Sildenafil and l-Arginine Administration in a Porcine Animal Model: Hemodynamic Safety Profile and Effects on Coronary Blood Flow

[1]  H. Shimokawa,et al.  Endothelial dysfunction and vascular disease – a 30th anniversary update , 2017, Acta physiologica.

[2]  E. Bae,et al.  Altered Nitric Oxide System in Cardiovascular and Renal Diseases , 2016, Chonnam medical journal.

[3]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[4]  L. Rivera,et al.  Role of nitric oxide in the relaxation elicited by sildenafil in penile resistance arteries. , 2006, The Journal of urology.

[5]  W. Zapol,et al.  Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. , 2005, Chest.

[6]  N. Gokce.  L-arginine and hypertension. , 2004, The Journal of nutrition.

[7]  A. Germain,et al.  Management of Eisenmenger Syndrome in Pregnancy With Sildenafil and l-arginine , 2004, Obstetrics and gynecology.

[8]  T. Daabees,et al.  Comparative effects of sildenafil, phentolamine, yohimbine and l‐arginine on the rabbit corpus cavernosum , 2004, Fundamental & clinical pharmacology.

[9]  K. Chayama,et al.  PDE5 Inhibitor Sildenafil Citrate Augments Endothelium-Dependent Vasodilation in Smokers , 2003, Hypertension.

[10]  A. Quyyumi,et al.  The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. , 2002, Journal of the American College of Cardiology.

[11]  S. Archer,et al.  Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension Comparison With Inhaled Nitric Oxide , 2002 .

[12]  E. Michelakis,et al.  Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide , 2002, Circulation.

[13]  J. Morgan,et al.  Transient ischemic attack and stroke associated with sildenafil (Viagra) use , 2001, Neurology.

[14]  C. Stefanadis,et al.  Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases. , 2001, Atherosclerosis.

[15]  V. Somers,et al.  Sympathetic Activation by Sildenafil , 2000, Circulation.

[16]  R. Bache,et al.  Cyclic Nucleotide Phosphodiesterase Type 5 Activity Limits Blood Flow to Hypoperfused Myocardium During Exercise , 2000, Circulation.

[17]  James B. Seward,et al.  Effects of Sildenafil Citrate (Viagra) Combined With Nitrate on the Heart , 2000, Circulation.

[18]  R. Bache,et al.  Effect of sildenafil on coronary active and reactive hyperemia. , 2000, American journal of physiology. Heart and circulatory physiology.

[19]  C. Stefanadis,et al.  L-Arginine in coronary atherosclerosis. , 2000, International journal of cardiology.

[20]  S. Homma,et al.  Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. , 2000, Journal of the American College of Cardiology.

[21]  D. Webb,et al.  Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. , 2000, Journal of the American College of Cardiology.

[22]  H. Herrmann,et al.  Hemodynamic effects of sildenafil in men with severe coronary artery disease. , 2000, The New England journal of medicine.

[23]  J. Loscalzo.  What we know and don't know about L-arginine and NO. , 2000, Circulation.

[24]  A. Wallace,et al.  Interaction of L-Arginine and Phosphodiesterase Inhibitors in Vasodilation of the Porcine Internal Mammary Artery , 2000, Anesthesia and analgesia.

[25]  M. Ratcliffe,et al.  L-arginine infusion dilates coronary vasculature in patients undergoing coronary bypass surgery. , 1999, Anesthesiology.

[26]  G. Jackson,et al.  Effects of sildenafil citrate on human hemodynamics. , 1999, The American journal of cardiology.

[27]  S. Kaul,et al.  Writing Group Members , 2022 .

[28]  D. Tsikas,et al.  L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. , 1998, British journal of clinical pharmacology.

[29]  S. Glantz,et al.  Effect of lidocaine on left ventricular pressure-volume curves during demand ischemia in pigs. , 1998, American journal of physiology. Heart and circulatory physiology.

[30]  R. Gibbons,et al.  Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.

[31]  P. Toutouzas,et al.  Coronary stenosis dilatation induced by L-arginine , 1997, The Lancet.

[32]  D. Tousoulis,et al.  Effects of inhibition of nitric oxide synthesis in patients with coronary artery disease and stable angina. , 1997, European heart journal.

[33]  D. Stewart,et al.  The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans. , 1996, Chest.

[34]  A. Keech,et al.  Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. , 1996, The Journal of clinical investigation.

[35]  J. Cooke,et al.  Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. , 1994, Circulation.

[36]  J. Cooke,et al.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. , 1992, The Journal of clinical investigation.

[37]  M. Brody,et al.  Coronary blood flow in rats is dependent on the release of vascular nitric oxide. , 1992, The Journal of pharmacology and experimental therapeutics.

[38]  H. Drexler,et al.  Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine , 1991, The Lancet.

[39]  P. Vallance,et al.  Dilator actions of arginine in human peripheral vasculature. , 1991, Clinical science.

[40]  M. Condorelli,et al.  Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. , 1991, The New England journal of medicine.

[41]  M. Yacoub,et al.  Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries , 1990, The Lancet.

[42]  M. Bettmann,et al.  The effects of radiographic contrast media on myocardial contractility and coronary resistance: osmolality, ionic concentration, and viscosity. , 1990, Investigative radiology.

[43]  P. Lichtlen,et al.  Impaired cholinergic vasodilation in the cholesterol-fed rabbit in vivo , 1987, Basic Research in Cardiology.

[44]  E. Eger,et al.  Pancuronium-induced tachycardia in relation to alveolar halothane, dose of pancuronium, and prior atropine. , 1975, Anesthesiology.

[45]  木村 祐之.  PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers , 2004 .